Inhibrx Biosciences (INBX) Return on Sales (2023 - 2025)

Inhibrx Biosciences (INBX) reported Return on Sales of 1.0% for Q4 2025, up 379.0% year-over-year from 0.21% in Q4 2024, and up 9.69% quarter-over-quarter from 1.11% in Q3 2025.

Inhibrx Biosciences (INBX) Return on Sales (2023 - 2025) Analysis & Trends

Inhibrx Biosciences (INBX) has 3 years of Return on Sales data on file, last reported at 1.0% in Q4 2025.

  • Return on Sales for Q4 2025 came in at 1.0%, up 379.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 1.0% (down 1020.0% YoY), and the FY2025 annual result was 1.08%, down 8546.0% from the prior year.
  • Return on Sales advanced to 1.0% in Q4 2025 per INBX's latest filing, from 1.11% in the prior quarter.
  • Over five years, Return on Sales peaked at 185.8% in Q2 2024 and troughed at 15.68% in Q2 2023.
  • A 3-year average of 18.55% and a median of 1.0% in 2025 frame the typical range for Return on Sales.
  • The sharpest annual moves came in 2024 and 2025: Return on Sales soared 20149 bps in 2024, then sank 18602 bps in 2025.
  • A 3-year view of Return on Sales shows it stood at 0.56% in 2023, then plunged by 750 bps to 4.79% in 2024, then surged by 79 bps to 1.0% in 2025.
  • Business Quant data shows INBX's Return on Sales at 1.0% in Q4 2025, 1.11% in Q3 2025, and 0.22% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.00%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 0.00%
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 0.00%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Inhibrx Biosciences 186.16 Mn 186.16 Mn - -1.00%

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.00%
Sep 30, 2025 -1.11%
Jun 30, 2025 -0.22%
Dec 31, 2024 -4.79%
Sep 30, 2024 8.87%
Jun 30, 2024 185.80%
Dec 31, 2023 -0.56%
Sep 30, 2023 -4.35%
Jun 30, 2023 -15.68%